Vascular disrupting agent drug classes differ in effects on the cytoskeleton
about
Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approachCecropinXJ, a silkworm antimicrobial peptide, induces cytoskeleton disruption in esophageal carcinoma cells.WTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo.Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.Recent advances in vascular disrupting agents in cancer therapy.Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer.Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.
P2860
Q28388409-E4CB0ACF-EA55-452A-8995-840D680CCB4DQ35224948-A9F23D82-0976-4B8A-B3B1-AE7690D4B5D9Q36124216-C7C5406F-9539-4D30-B0D9-F043FEE396A4Q37130150-B0629A42-093F-40D5-9434-6FD283E631C4Q38264533-55A41842-2E66-48B1-A7BA-9F846784FE14Q48444978-38BA88CE-54FC-45A0-B011-FF2A0C5FE6BDQ51795514-5620ED2D-F53F-4606-8E9C-A0BA818BD3D8Q55020612-0DF9BBDC-9066-4E11-A046-BCCD8569598C
P2860
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@ast
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@en
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@nl
type
label
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@ast
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@en
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@nl
prefLabel
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@ast
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@en
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@nl
P2860
P1433
P1476
Vascular disrupting agent drug classes differ in effects on the cytoskeleton
@en
P2093
Sujeong Kim
Timothy J Mitchison
P2860
P304
P356
10.1371/JOURNAL.PONE.0040177
P407
P577
2012-07-24T00:00:00Z